- Home
- MMLP vs SAVA Comparison
MMLP vs SAVA Comparison
Compare MMLP & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- SAVA
- Stock Information
- Founded
- MMLP 2002
- SAVA 1998
- Country
- MMLP United States
- SAVA United States
- Employees
- MMLP N/A
- SAVA N/A
- Industry
- MMLP Oil Refining/Marketing
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- MMLP Energy
- SAVA Health Care
- Exchange
- MMLP Nasdaq
- SAVA Nasdaq
- Market Cap
- MMLP 139.6M
- SAVA 113.8M
- IPO Year
- MMLP 2002
- SAVA N/A
- Fundamental
- Price
- MMLP $3.58
- SAVA $2.55
- Analyst Decision
- MMLP
- SAVA Buy
- Analyst Count
- MMLP 0
- SAVA 3
- Target Price
- MMLP N/A
- SAVA $111.50
- AVG Volume (30 Days)
- MMLP 84.3K
- SAVA 1.3M
- Earning Date
- MMLP 02-12-2025
- SAVA 03-07-2025
- Dividend Yield
- MMLP 0.56%
- SAVA N/A
- EPS Growth
- MMLP N/A
- SAVA N/A
- EPS
- MMLP N/A
- SAVA N/A
- Revenue
- MMLP $707,622,000.00
- SAVA N/A
- Revenue This Year
- MMLP $4.19
- SAVA N/A
- Revenue Next Year
- MMLP N/A
- SAVA N/A
- P/E Ratio
- MMLP N/A
- SAVA N/A
- Revenue Growth
- MMLP N/A
- SAVA N/A
- 52 Week Low
- MMLP $2.28
- SAVA $2.23
- 52 Week High
- MMLP $4.13
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- MMLP 48.48
- SAVA 41.47
- Support Level
- MMLP $3.44
- SAVA $2.25
- Resistance Level
- MMLP $3.67
- SAVA $2.36
- Average True Range (ATR)
- MMLP 0.17
- SAVA 0.14
- MACD
- MMLP 0.00
- SAVA 0.17
- Stochastic Oscillator
- MMLP 45.16
- SAVA 50.85
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.